Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News MannKind Corporation MNKD

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.

The Power Play by The Market Herald
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Stock Price Chart (NDAQ:MNKD)

Fundamentals Snapshot (NDAQ:MNKD)

Opinion & Analysis (NDAQ:MNKD)

No current opinion is available.

Bullboard Posts (NDAQ:MNKD)

slow & steady for this one

climbing up ,so glta .
coolfooldumbguy - January 15, 2019

it's a buy today for me

it looks like a turnaround situation,so glta.
coolfooldumbguy - January 14, 2019

FINANCIALS ARE OUT

https://www.nasdaq.com/press-release/mannkind-corporation-reports-2018-third-quarter-financial-results-20181101-00761
Interpolation2 - November 1, 2018

RE:RE:RE:Chart is looking explosive

Well, I bought back in Friday. Stock looks ripe again. I think we are in for good times again, soon. Ando
ando - September 30, 2018

RE:RE:Chart is looking explosive

At the time I wrote that they stock was somewhere around 1.50. It went above 6.00 in a couple months so I don't think that is too bad...
ando - August 6, 2018

RE:Chart is looking explosive

I don't know if you were just guessing but man were you right.  
NovaAU10000 - October 5, 2017